A Phase I Placebo-Controlled, Open-Label, Crossover Study to Assess the Reversibility of Apixaban Anticoagulation With the Four Factor Prothrombin Complex Concentrate Kcentra in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 15 Jun 2016
At a glance
- Drugs Prothrombin complex concentrate (Primary) ; Apixaban
- Indications Haemorrhage
- Focus Therapeutic Use
- Acronyms 4PAR
- 12 Mar 2016 Results presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
- 21 Jan 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Dec 2014 Planned End Date changed from 1 Mar 2015 to 1 Feb 2015 as reported by ClinicalTrials.gov.